Board Review for Hematopathology
Andy Nguyen, MD
UT-Medical School at Houston, Pathology
Last Revision on: 10/8/2022
PART 1A:
Board Review- Part 1A: Benign Hematopathology
PART 1B:
Board Review- Part 1B: Benign Hematopathology
PART 2A:
Board Review- Part 2A: Malignant Hematopathology
PART 2B:
Board Review- Part 2B: Malignant Hematopathology
PART 2C:
Board Review- Part 2C: Malignant Hematopathology
PART 3:
Board Review- Part 3: Coagulation
Summary of 5th Edition of the World Health Organization classification of Hematological Malignancies:
Myeloid and Histiocytic/Dendritic Neoplasms
- Leukemia (2022) 36:1703-1719
Lymphoid Neoplasms
- Leukemia (2022) 36:1720-1748
Some key algorithms for the 5th Edition